Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-18.25	-1023.69	1252.15
Graham Fair Price	82.56	9.11	4.99
PEG	-94.52	0.03	-0.58
Price/Book	8.49	0.99	0.91
Price/Cash Flow	208.86	41.50	13.44
Prices/Earnings	-68.00	16.44	51.37
Price/Sales	7.06	5.38	5.02
Price/FCF	208.86	41.50	13.44
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-86.66	0.10	0.78
ROA	238.35	< 0.005	< 0.005
ROE	< 0.005	0.02	239.01
ROIC	0.06	< 0.005	-90.95
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	-0.09	-45.82
Dividends QOQ	< 0.005	< 0.005	-48.93
EBIT QOQ	4.62	-0.87	-81.27
EPS QOQ	-0.89	5.19	484.27
FCF QOQ	0.84	-0.65	-22.26
Revenue QOQ	0.75	< 0.005	-99.05
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	118.08	110.09	-6.77
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.61	0.62	2.02
Quick Ratio	0.20	0.80	293.82
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	15.78	15.65	-0.85
Cash	21.91	24.33	11.00
Capex	-0.05	-0.01	72.16
Free Cash Flow	1.07	0.37	-65.17
Revenue	2.87	2.88	0.48
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.11	0.50	352.97
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	775.14	-623.67	-19.54
Naive Interpretation	Member

06 - Financial Health · Bad

Rating